Low protein diets for non‐diabetic adults with chronic kidney disease

D Hahn, EM Hodson, D Fouque - Cochrane Database of …, 2018 - cochranelibrary.com
Background Chronic kidney disease (CKD) is defined as reduced function of the kidneys
present for 3 months or longer with adverse implications for health and survival. For several …

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the …

DA Calhoun, D Jones, S Textor, DC Goff, TP Murphy… - …, 2008 - Am Heart Assoc
Resistant hypertension is a common clinical problem faced by both primary care clinicians
and specialists. While the exact prevalence of resistant hypertension is unknown, clinical …

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation

AS Levey, JP Bosch, JB Lewis, T Greene… - Annals of internal …, 1999 - acpjournals.org
Background: Serum creatinine concentration is widely used as an index of renal function,
but this concentration is affected by factors other than glomerular filtration rate (GFR) …

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

AS Levey, J Coresh, K Bolton, B Culleton… - American Journal of …, 2002 - experts.umn.edu
Introduction: Chronic kidney disease as a public health problem. Chronic kidney disease is
a worldwide public health problem. In the United States, there is a rising incidence and …

Premature cardiovascular disease in chronic renal failure

C Baigent, K Burbury, D Wheeler - The lancet, 2000 - thelancet.com
There is a remarkable lack of reliable information about the determinants of risk of
cardiovascular disease (CVD) among patients with chronic renal failure. Indeed, such …

Epidemiology of hypertension in CKD

B Horowitz, D Miskulin, P Zager - Advances in chronic kidney disease, 2015 - Elsevier
Both hypertension (HTN) and CKD are serious interrelated global public health problems.
Nearly 30% and 15% of US adults have HTN and CKD, respectively. Because HTN may …

[图书][B] Brenner and Rector's The Kidney E-Book

MW Taal, GM Chertow, PA Marsden, K Skorecki… - 2011 - books.google.com
Overcome the toughest clinical challenges in nephrology with the new 9th edition of
Brenner/Rector's The Kidney! A brand-new editorial team of Drs. Maarten W. Taal, Glenn M …

Left ventricular hypertrophy in nondiabetic predialysis CKD

E Paoletti, D Bellino, P Cassottana, D Rolla… - American journal of …, 2005 - Elsevier
Background: Although left ventricular hypertrophy (LVH) is a strong predictor of mortality in
patients with end-stage renal disease, few studies are available before the start of dialysis …

Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy

A Ortiz, JP Oliveira, S Waldek… - Nephrology Dialysis …, 2008 - academic.oup.com
Background. Fabry disease, an X-linked genetic disorder with deficient α-galactosidase A
activity, is characterized by kidney disease and kidney failure. The spectrum of kidney …

Long‐term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function

MK Menon, DM Naimark, JM Bargman… - Nephrology Dialysis …, 2001 - academic.oup.com
Background. Hypertension is the prime contributor for cardiovascular mortality in the dialysis
population. Peritoneal dialysis (PD) has been thought to improve blood pressure (BP) …